Potential Plasticity of the Mannoprotein Repertoire Associated to Mycobacterium tuberculosis Virulence Unveiled by Mass Spectrometry-Based Glycoproteomics
Abstract:To date, Mycobacterium tuberculosis (Mtb) remains the world’s greatest infectious killer. The rise of multidrug-resistant strains stresses the need to identify new therapeutic targets to fight the epidemic. We previously demonstrated that bacterial protein-O-mannosylation is crucial for Mtb infectiousness, renewing the interest of the bacterial-secreted mannoproteins as potential drug-targetable virulence factors. The difficulty of inventorying the mannoprotein repertoire expressed by Mtb led us to design a st… Show more
“…To date, multiple mycobacterial mannoproteins have been identified, with potential roles in virulence, cell invasion, evasion of host defense, and host immunomodulation, reviewed in Mehaffy et al (2019) , Deng et al (2020) , and Tonini et al (2020) . Many of these antigenic glycoproteins contain acyl groups and are defined as lipoglycoproteins ( Becker and Sander, 2016 ).…”
Section: Adaptation Of Drug-resistant
Mtb
Strainsmentioning
confidence: 99%
“…Other groups of glycoproteins involved in M.tb –host interactions are the ones belonging to the MCE family, MPT64, or Apa, among others, involved in colonization and invasion of host cells ( Sonawane et al, 2012 ), as well as other proteins such as Rv0227c, HtrA-like serine protease Rv1223, TatA, GlnA1, and the disulfide oxidase DsbA-like enzyme Rv2969c, recently described as mannosylated ( Tonini et al, 2020 ). In addition, GroEL2, a chaperone-like M.tb capsule-associated glycoprotein, is shown to contribute to the suboptimal antigen presentation during mycobacterial infection by modulating macrophage and DC proinflammatory responses ( Georgieva et al, 2018 ), supporting the immunogenic role of M.tb cell envelope-associated glycoproteins during M.tb infection.…”
Section: Adaptation Of Drug-resistant
Mtb
Strainsmentioning
In the last two decades, multi (MDR), extensively (XDR), extremely (XXDR) and total (TDR) drug-resistant Mycobacterium tuberculosis (M.tb) strains have emerged as a threat to public health worldwide, stressing the need to develop new tuberculosis (TB) prevention and treatment strategies. It is estimated that in the next 35 years, drug-resistant TB will kill around 75 million people and cost the global economy $16.7 trillion. Indeed, the COVID-19 pandemic alone may contribute with the development of 6.3 million new TB cases due to lack of resources and enforced confinement in TB endemic areas. Evolution of drug-resistant M.tb depends on numerous factors, such as bacterial fitness, strain’s genetic background and its capacity to adapt to the surrounding environment, as well as host-specific and environmental factors. Whole-genome transcriptomics and genome-wide association studies in recent years have shed some insights into the complexity of M.tb drug resistance and have provided a better understanding of its underlying molecular mechanisms. In this review, we will discuss M.tb phenotypic and genotypic changes driving resistance, including changes in cell envelope components, as well as recently described intrinsic and extrinsic factors promoting resistance emergence and transmission. We will further explore how drug-resistant M.tb adapts differently than drug-susceptible strains to the lung environment at the cellular level, modulating M.tb–host interactions and disease outcome, and novel next generation sequencing (NGS) strategies to study drug-resistant TB.
“…To date, multiple mycobacterial mannoproteins have been identified, with potential roles in virulence, cell invasion, evasion of host defense, and host immunomodulation, reviewed in Mehaffy et al (2019) , Deng et al (2020) , and Tonini et al (2020) . Many of these antigenic glycoproteins contain acyl groups and are defined as lipoglycoproteins ( Becker and Sander, 2016 ).…”
Section: Adaptation Of Drug-resistant
Mtb
Strainsmentioning
confidence: 99%
“…Other groups of glycoproteins involved in M.tb –host interactions are the ones belonging to the MCE family, MPT64, or Apa, among others, involved in colonization and invasion of host cells ( Sonawane et al, 2012 ), as well as other proteins such as Rv0227c, HtrA-like serine protease Rv1223, TatA, GlnA1, and the disulfide oxidase DsbA-like enzyme Rv2969c, recently described as mannosylated ( Tonini et al, 2020 ). In addition, GroEL2, a chaperone-like M.tb capsule-associated glycoprotein, is shown to contribute to the suboptimal antigen presentation during mycobacterial infection by modulating macrophage and DC proinflammatory responses ( Georgieva et al, 2018 ), supporting the immunogenic role of M.tb cell envelope-associated glycoproteins during M.tb infection.…”
Section: Adaptation Of Drug-resistant
Mtb
Strainsmentioning
In the last two decades, multi (MDR), extensively (XDR), extremely (XXDR) and total (TDR) drug-resistant Mycobacterium tuberculosis (M.tb) strains have emerged as a threat to public health worldwide, stressing the need to develop new tuberculosis (TB) prevention and treatment strategies. It is estimated that in the next 35 years, drug-resistant TB will kill around 75 million people and cost the global economy $16.7 trillion. Indeed, the COVID-19 pandemic alone may contribute with the development of 6.3 million new TB cases due to lack of resources and enforced confinement in TB endemic areas. Evolution of drug-resistant M.tb depends on numerous factors, such as bacterial fitness, strain’s genetic background and its capacity to adapt to the surrounding environment, as well as host-specific and environmental factors. Whole-genome transcriptomics and genome-wide association studies in recent years have shed some insights into the complexity of M.tb drug resistance and have provided a better understanding of its underlying molecular mechanisms. In this review, we will discuss M.tb phenotypic and genotypic changes driving resistance, including changes in cell envelope components, as well as recently described intrinsic and extrinsic factors promoting resistance emergence and transmission. We will further explore how drug-resistant M.tb adapts differently than drug-susceptible strains to the lung environment at the cellular level, modulating M.tb–host interactions and disease outcome, and novel next generation sequencing (NGS) strategies to study drug-resistant TB.
“…tuberculosis strains. We quantified the transcript levels of Erd_0925 (secreted lipoprotein), Erd_0927 (MenA2), Erd_0929 (glycosylated protein) and Erd_0930 (conserved hypothetical protein) in wild-type and ΔmenT2 strains [70, 71]. The relative transcript levels of menT2 -adjacent genes were comparable in both strains ().…”
Section: Resultsmentioning
confidence: 99%
“…The lack of complete restoration of the growth defect for the ΔmenT2 mutant strain in guinea pigs prompted us to investigate the effect of deletion of MenT2 on the expression of neighbouring genes and on lipid profiles of M. tuberculosis strains. We quantified the transcript levels of Erd_0925 (secreted lipoprotein), Erd_0927 (MenA2), Erd_0929 (glycosylated protein) and Erd_0930 (conserved hypothetical protein) in wild-type and ΔmenT2 strains [70,71]. The relative transcript levels of menT2-adjacent genes were comparable in both strains (Fig.…”
Section: Replacement Of Ment2 With the Hygromycin Resistance Gene Doe...mentioning
Toxin–antitoxin (TA) systems are abundantly present in the genomes of various bacterial pathogens. TA systems have been implicated in either plasmid maintenance or protection against phage infection, stress adaptation or disease pathogenesis. The genome of
Mycobacterium tuberculosis
encodes for more than 90 TA systems and 4 of these belong to the type IV subfamily (MenAT family). The toxins and antitoxins belonging to type IV TA systems share sequence homology with the AbiEii family of nucleotidyl transferases and the AbiEi family of putative transcriptional regulators, respectively. Here, we have performed experiments to understand the role of MenT2, a toxin from the type IV TA system, in mycobacterial physiology and disease pathogenesis. The ectopic expression of MenT2 using inducible vectors does not inhibit bacterial growth in liquid cultures. Bioinformatic and molecular modelling analysis suggested that the
M. tuberculosis
genome has an alternative start site upstream of the annotated menT2 gene. The overexpression of the reannotated MenT2 resulted in moderate growth inhibition of
Mycobacterium smegmatis
. We show that both menT2 and menA2 transcript levels are increased when
M. tuberculosis
is exposed to nitrosative stress, in vitro. When compared to the survival of the wild-type and the complemented strain, the ΔmenT2 mutant strain of
M. tuberculosis
was more resistant to being killed by nitrosative stress. However, the survival of both the ΔmenT2 mutant and the wild-type strain was similar in macrophages and when exposed to other stress conditions. Here, we show that MenT2 is required for the establishment of disease in guinea pigs. Gross pathology and histopathology analysis of lung tissues from guinea pigs infected with the ∆menT2 strain revealed significantly reduced tissue damage and inflammation. In summary, these results provide new insights into the role of MenT2 in mycobacterial pathogenesis.
“…The core principle of NCBA is cell enrichment through GMNP, due to its glycan interaction with the Mtb cell envelope, which is rich in complex carbohydrates, glycoproteins, and lipids [ 23 , 24 ]. These characteristics allow the formation of complexes between GMNP-AFB by Brownian motion, hydrodynamic force, and physicochemical and molecular interactions.…”
Despite its reduced sensitivity, sputum smear microscopy (SSM) remains the main diagnostic test for detecting tuberculosis in many parts of the world. A new diagnostic technique, the magnetic nanoparticle-based colorimetric biosensing assay (NCBA) was optimized by evaluating different concentrations of glycan-functionalized magnetic nanoparticles (GMNP) and Tween 80 to improve the acid-fast bacilli (AFB) count. Comparative analysis was performed on 225 sputum smears: 30 with SSM, 107 with NCBA at different GMNP concentrations, and 88 with NCBA-Tween 80 at various concentrations and incubation times. AFB quantification was performed by adding the total number of AFB in all fields per smear and classified according to standard guidelines (scanty, 1+, 2+ and 3+). Smears by NCBA with low GMNP concentrations (≤1.5 mg/mL) showed higher AFB quantification compared to SSM. Cell enrichment of sputum samples by combining NCBA-GMNP, incubated with Tween 80 (5%) for three minutes, improved capture efficiency and increased AFB detection up to 445% over SSM. NCBA with Tween 80 offers the opportunity to improve TB diagnostics, mainly in paucibacillary cases. As this method provides biosafety with a simple and inexpensive methodology that obtains results in a short time, it might be considered as a point-of-care TB diagnostic method in regions where resources are limited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.